GB9109506D0 - Therapeutic nucleosides - Google Patents

Therapeutic nucleosides

Info

Publication number
GB9109506D0
GB9109506D0 GB919109506A GB9109506A GB9109506D0 GB 9109506 D0 GB9109506 D0 GB 9109506D0 GB 919109506 A GB919109506 A GB 919109506A GB 9109506 A GB9109506 A GB 9109506A GB 9109506 D0 GB9109506 D0 GB 9109506D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919109506A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB919109506A priority Critical patent/GB9109506D0/en
Publication of GB9109506D0 publication Critical patent/GB9109506D0/en
Priority to MYPI92000749A priority patent/MY137298A/en
Priority to ZA923185A priority patent/ZA923185B/xx
Priority to PT100435A priority patent/PT100435B/pt
Priority to CA002102120A priority patent/CA2102120A1/en
Priority to IL101757A priority patent/IL101757A0/xx
Priority to UA93004171A priority patent/UA37251C2/uk
Priority to EP92908933A priority patent/EP0583274A1/en
Priority to JP4508657A priority patent/JPH06506929A/ja
Priority to AU16620/92A priority patent/AU1662092A/en
Priority to RU93058325A priority patent/RU2104700C1/ru
Priority to PCT/GB1992/000803 priority patent/WO1992019246A1/en
Priority to MX9203214A priority patent/MX9203214A/es
Priority to IE136392A priority patent/IE921363A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB919109506A 1991-05-02 1991-05-02 Therapeutic nucleosides Pending GB9109506D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB919109506A GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides
MYPI92000749A MY137298A (en) 1991-05-02 1992-04-30 Therapeutic nucleosides
ZA923185A ZA923185B (en) 1991-05-02 1992-04-30 Therapeutic nucleosides
PT100435A PT100435B (pt) 1991-05-02 1992-04-30 Nucleosidos terapeuticos
PCT/GB1992/000803 WO1992019246A1 (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
UA93004171A UA37251C2 (uk) 1991-05-02 1992-05-01 Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в
IL101757A IL101757A0 (en) 1991-05-02 1992-05-01 Pharmaceutical compositions containing a 1,3-oxathiolane analogue
CA002102120A CA2102120A1 (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathlolan derivative for the treatment of hepatitis b infection
EP92908933A EP0583274A1 (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
JP4508657A JPH06506929A (ja) 1991-05-02 1992-05-01 Ｂ型肝炎ウイルス感染の治療のための、１，３−オキサチオラン誘導体の使用
AU16620/92A AU1662092A (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
RU93058325A RU2104700C1 (ru) 1991-05-02 1992-05-01 Способ лечения гепатита в
MX9203214A MX9203214A (es) 1991-05-02 1992-06-24 Nucleosidos terapeuticos.
IE136392A IE921363A1 (en) 1991-05-02 1992-07-01 Therapeutic nucleosides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919109506A GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides

Publications (1)

Publication Number Publication Date
GB9109506D0 true GB9109506D0 (en) 1991-06-26

Family

ID=10694346

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919109506A Pending GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides

Country Status (14)

Country Link
EP (1) EP0583274A1 (es)
JP (1) JPH06506929A (es)
AU (1) AU1662092A (es)
CA (1) CA2102120A1 (es)
GB (1) GB9109506D0 (es)
IE (1) IE921363A1 (es)
IL (1) IL101757A0 (es)
MX (1) MX9203214A (es)
MY (1) MY137298A (es)
PT (1) PT100435B (es)
RU (1) RU2104700C1 (es)
UA (1) UA37251C2 (es)
WO (1) WO1992019246A1 (es)
ZA (1) ZA923185B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
DK1140937T3 (da) 1998-12-23 2004-03-22 Shire Biochem Inc Antivirale nucleosid-analoger

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
AU5659990A (en) * 1989-05-15 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of treatment of hepatitis
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds

Also Published As

Publication number Publication date
RU2104700C1 (ru) 1998-02-20
ZA923185B (en) 1993-11-01
CA2102120A1 (en) 1992-11-03
WO1992019246A1 (en) 1992-11-12
UA37251C2 (uk) 2001-05-15
IE921363A1 (en) 1992-11-04
PT100435A (pt) 1993-09-30
PT100435B (pt) 1999-08-31
EP0583274A1 (en) 1994-02-23
MY137298A (en) 2009-01-30
IL101757A0 (en) 1992-12-30
AU1662092A (en) 1992-12-21
JPH06506929A (ja) 1994-08-04
MX9203214A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
GB8815265D0 (en) Therapeutic nucleosides
GR3031100T3 (en) Therapeutic nucleosides
GB9105899D0 (en) Therapeutic nucleosides
EP0356166A3 (en) Therapeutic nucleosides
GB9200150D0 (en) Therapeutic nucleosides
GB9109506D0 (en) Therapeutic nucleosides
GB8823353D0 (en) Therapeutic nucleosides
ZA911154B (en) Therapeutic nucleosides
GB8912972D0 (en) Therapeutic nucleosides
ZA921658B (en) Therapeutic nucleosides
GB9109505D0 (en) Therapeutic nucleosides
GB9105028D0 (en) Therapeutic nucleosides
AU2641192A (en) Therapeutic nucleosides
GB9016775D0 (en) Therapeutic nucleosides
GB9214171D0 (en) Therapeutic nucleosides
GB9223178D0 (en) Therapeutic nucleosides
GB9214170D0 (en) Therapeutic nucleosides
GB9204026D0 (en) Therapeutic nucleosides
GB9214172D0 (en) Therapeutic nucleosides
GB9220317D0 (en) Therapeutic nucleosides
GB9208017D0 (en) Therapeutic nucleosides
GB9223181D0 (en) Therapeutic nucleosides
GB9223180D0 (en) Therapeutic nucleosides
GB9200149D0 (en) Therapeutic nucleosides
GB9220156D0 (en) Therapeutic nucleosides